Basic Fibroblast Growth Factor Fused with Tandem Collagen-Binding Domains from

PubMed オープンアクセス

この論文をさがす

説明

Basic fibroblast growth factor 2 (bFGF) accelerates bone formation during fracture healing. Because the efficacy of bFGF decreases rapidly following its diffusion from fracture sites, however, repeated dosing is required to ensure a sustained therapeutic effect. We previously developed a fusion protein comprising bFGF, a polycystic kidney disease domain (PKD; s2b), and collagen-binding domain (CBD; s3) sourced from the

収録刊行物

詳細情報 詳細情報について

  • CRID
    1870865118108591744
  • ISSN
    23146141
  • PubMed
    29770338
  • データソース種別
    • OpenAIRE

問題の指摘

ページトップへ